The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.

[1]  L. Gustafsson,et al.  Metabolic interaction between morphine and various benzodiazepines. , 2009, Acta pharmacologica et toxicologica.

[2]  P. Edlund,et al.  Simultaneous determination of codeine and morphine in biological samples by gas chromatography with electron capture detection. , 2009, Acta pharmacologica et toxicologica.

[3]  L. Terenius.  Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. , 2009, Acta pharmacologica et toxicologica.

[4]  T. Nabika,et al.  A NEW LOCUS ON CHROMOSOME 3 STRONGLY LINKED WITH SALT‐SENSITIVE HIGH BLOOD PRESSURE IN FEMALE F2 FROM SHRSP AND WKY RATS , 1995, Clinical and experimental pharmacology & physiology. Supplement.

[5]  John Lynch,et al.  Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study , 1995, Pain.

[6]  G. Pasternak,et al.  Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats , 1995, Neuroscience Letters.

[7]  G. Pasternak,et al.  Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor , 1995, FEBS letters.

[8]  M. Plotkine,et al.  Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat. , 1995, The Journal of pharmacology and experimental therapeutics.

[9]  M. Slevin,et al.  Respiratory depression following morphine and morphine-6-glucuronide in normal subjects. , 1995, British journal of clinical pharmacology.

[10]  K. Ullrich,et al.  Morphine Analogues: Relationship between Chemical Structure and Interaction with Proximal Tubular Transporters – Contraluminal Organic Cation and Anion Transporter, Luminal H+ /Organic Cation Exchanger, and Luminal Choline Transporter , 1995 .

[11]  Maree T. Smith,et al.  Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat , 1995, Pain.

[12]  S. Bartlett,et al.  The apparent affinity of morphine-3-glucuronide at mu1-opioid receptors results from morphine contamination: demonstration using HPLC and radioligand binding. , 1995, Life sciences.

[13]  M. Green,et al.  Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin. , 1995, Molecular pharmacology.

[14]  J. Plummer,et al.  Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution , 1995, Pain.

[15]  D Westerling,et al.  Plasma Concentrations of Morphine, Morphine‐3‐Glucuronide, and Morphine‐6‐Glucuronide After Intravenous and Oral Administration to Healthy Volunteers: Relationship to Nonanalgesic Actions , 1995, Therapeutic drug monitoring.

[16]  S. Joel,et al.  A Specific Radioimmunoassay for the Determination of Morphine-6-Glucuronide in Human Plasma , 1995, Annals of clinical biochemistry.

[17]  C. Abdallah,et al.  Presystemic elimination of morphine in anesthetized rabbits. Contribution of the intestine, liver, and lungs. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[18]  A. Evans,et al.  The Disposition of Morphine and Its Metabolites in the In‐situ Rat Isolated Perfused Liver , 1995, The Journal of pharmacy and pharmacology.

[19]  G. Pollack,et al.  Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[20]  W. Runciman,et al.  Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[21]  R. Pacifici,et al.  High-performance liquid chromatographic-electrospray mass spectrometric determination of morphine and its 3- and 6-glucuronides: application to pharmacokinetic studies. , 1995, Journal of chromatography. B, Biomedical applications.

[22]  C. Mignat,et al.  Plasma and Cerebrospinal Fluid Concentrations of Morphine and Morphine Glucuronides in Rabbits Receiving Single and Repeated Doses of Morphine , 1995, The Journal of pharmacy and pharmacology.

[23]  U. Wille,et al.  Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. , 1995, Life sciences.

[24]  K. Tsuruda,et al.  Purification of a phenobarbital-inducible morphine UDP-glucuronyltransferase isoform, absent from Gunn rat liver. , 1994, Archives of biochemistry and biophysics.

[25]  N. Abumrad,et al.  Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6-glucuronide , 1994, Brain Research.

[26]  K. Sugibayashi,et al.  The effect of different routes of administration on the metabolism of morphine: The disposition of morphine and its metabolites after topical application , 1994, Biopharmaceutics & drug disposition.

[27]  T. Vree,et al.  Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine. , 1994, British journal of clinical pharmacology.

[28]  D. Lambert,et al.  Update on opioid receptors. , 1994, British journal of anaesthesia.

[29]  P. Dodd,et al.  Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. , 1994, Pharmacology & toxicology.

[30]  F. Belleville,et al.  Gas chromatographic-mass spectrometric procedures used for the identification and determination of morphine, codeine and 6-monoacetylmorphine. , 1994, Journal of chromatography. A.

[31]  G. Dhonneur,et al.  Plasma and Cerebrospinal Fluid Concentrations of Morphine and Morphine Glucuronides after Oral Morphine: The Influence of Renal Failure , 1994, Anesthesiology.

[32]  S. Lundin,et al.  Transdermal administration of morphine to healthy subjects. , 1994, British journal of clinical pharmacology.

[33]  G. Geisslinger,et al.  Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum. , 1994, European journal of pharmacology.

[34]  Maree T. Smith,et al.  Quantitation of Morphine, Morphine‐3‐Glucuronide, and Morphine‐6‐Glucuronide in Plasma and Cerebrospinal Fluid Using Solid‐Phase Extraction and High‐Performance Liquid Chromatography with Electrochemical Detection , 1994, Therapeutic drug monitoring.

[35]  P. Massi,et al.  Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization. , 1994, European journal of pharmacology.

[36]  S. Joel,et al.  Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma. , 1994, Journal of pharmaceutical and biomedical analysis.

[37]  K. Ilett,et al.  Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain , 1994, Pain.

[38]  R. Dirksen,et al.  Pharmacokinetics of Intravenously Administered Nicomorphine and its Metabolites and Glucuronide Conjugates in Surgical Patients , 1994 .

[39]  B. Bayer,et al.  Immunosuppression by morphine is mediated by central pathways. , 1993, The Journal of pharmacology and experimental therapeutics.

[40]  G. Bell,et al.  Molecular biology of opioid receptors , 1993, Trends in Neurosciences.

[41]  M. Hammarlund-Udenaes,et al.  Quantification of effect delay and acute tolerance development to morphine in the rat. , 1993, The Journal of pharmacology and experimental therapeutics.

[42]  D. Taylor,et al.  Ion-pair extraction and liquid chromatographic analysis of morphine in rat brain and plasma. , 1993, Journal of chromatography.

[43]  A. Vaccarino,et al.  Morphine fails to produce tolerance when administered in the presence of formalin pain in rats , 1993, Brain Research.

[44]  E. Kalso,et al.  Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats. , 1993, European journal of pharmacology.

[45]  E. Bruera,et al.  Subcutaneous Morphine for Dyspnea in Cancer Patients , 1993, Annals of Internal Medicine.

[46]  Margaret Wood,et al.  Ethnic differences in response to morphine , 1993 .

[47]  L. Dragsted,et al.  Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure , 1993, Acta anaesthesiologica Scandinavica.

[48]  F. Breheny,et al.  Disposition and Clinical Effects of Morphine, Morphine-6-Glucuronide and Morphine-3-Glucuronide Following an Intentional Overdose of Slow Release Oral Morphine in a Patient with Renal Failure , 1993 .

[49]  W. Runciman,et al.  Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[50]  A. Vaccarino,et al.  Formalin-induced pain antagonizes the development of opiate dependence in the rat , 1993, Neuroscience Letters.

[51]  D. Lambert,et al.  Effects of morphine and its metabolites on opiate receptor binding, cAMP formation and [3H]noradrenaline release from SH-SY5Y cells. , 1993, Biochemical pharmacology.

[52]  Maree T. Smith,et al.  Determination of the Serum Protein Binding of Oxycodone and Morphine Using Ultrafiltration , 1993, Therapeutic drug monitoring.

[53]  Yamamoto Ken-ichi,et al.  Physical dependence on morphine induced in dogs via the use of miniosmotic pumps. , 1993 .

[54]  P. Höglund,et al.  Morphine Pharmacokinetics and Effects on Salivation and Continuous Reaction Times in Healthy Volunteers , 1993, Therapeutic drug monitoring.

[55]  J. Mørland,et al.  Different biotransformation of morphine in isolated liver cells from guinea pig and rat. , 1993, Biochemical pharmacology.

[56]  K. Andersson,et al.  Effects of morphine metabolites on micturition in normal, unanaesthetized rats , 1993, British journal of pharmacology.

[57]  Y. Ishii,et al.  Purification and characterization of a morphine UDP-glucuronyltransferase isoform from untreated rat liver. , 1993, Biological & pharmaceutical bulletin.

[58]  S. Joel,et al.  The pharmacokinetics of morphine and morphine glucuronides in kidney failure , 1993, Clinical pharmacology and therapeutics.

[59]  L. Murphey,et al.  A Stereospecific Microassay for the Determination of Morphine-6-β-D-Glucuronide and other Active Morphine Metabolites in the Neonatal Guinea Pig , 1993 .

[60]  W. Thormann,et al.  Determination of morphine-3-glucuronide in human urine by capillary zone electrophoresis and micellar electrokinetic capillary chromatography. , 1993, Journal of Chromatography A.

[61]  L. Paalzow,et al.  Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[62]  F. Tagliaro,et al.  Capillary electrophoresis for the investigation of illicit drugs in hair: determination of cocaine and morphine. , 1993, Journal of chromatography.

[63]  I. Tebbett,et al.  High-performance liquid chromatographic determination of morphine and its metabolites in plasma using diode-array detection. , 1993, Journal of chromatography.

[64]  A. Somogyi,et al.  Plasma Concentrations and Renal Clearance of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Cancer Patients Receiving Morphine , 1993, Clinical pharmacokinetics.

[65]  S. Peat,et al.  Morphine-6-glucuronide disposition in renal impairment. , 1993, British journal of anaesthesia.

[66]  A. Dickenson,et al.  Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study , 1993, Pain.

[67]  J. Hasselström,et al.  Morphine Pharmacokinetics and Metabolism in Humans , 1993, Clinical pharmacokinetics.

[68]  P. Tiseo,et al.  Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. , 1993, The Journal of pharmacology and experimental therapeutics.

[69]  J. Blumer,et al.  Pediatric intensive care sedation: survey of fellowship training programs. , 1993, Pediatrics.

[70]  M. Hammarlund-Udenaes,et al.  Pharmacokinetics and pharmacodynamics of morphine‐3‐glucuronide in rats and its influence on the antinociceptive effect of morphine , 1993, Biopharmaceutics & drug disposition.

[71]  G. Pasternak,et al.  NG-nitro-L-arginine prevents morphine tolerance. , 1992, European journal of pharmacology.

[72]  U. Klotz,et al.  Glucuronidation of Drugs , 1992, Clinical pharmacokinetics.

[73]  S. Joel,et al.  The analgesic activity of morphine-6-glucuronide. , 1992, British journal of clinical pharmacology.

[74]  B. Monsarrat,et al.  Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. , 1992, The Journal of pharmacology and experimental therapeutics.

[75]  A. Somogyi,et al.  The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients. , 1992, British journal of clinical pharmacology.

[76]  Nagamatsu Kunisuke,et al.  Covalent binding of morphine to isolated rat hepatocytes , 1992 .

[77]  J. Morley,et al.  Differential inhibition of hepatic morphine UDP-glucuronosyltransferases by metal ions. , 1992, Biochemical pharmacology.

[78]  M. Slevin,et al.  Morphine 6‐glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret , 1992, British journal of pharmacology.

[79]  H. Thaler,et al.  The metabolite morphine‐6‐glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function , 1992, Clinical pharmacology and therapeutics.

[80]  A. Burm,et al.  Uptake of sufentanil, alfentanil and morphine in the lungs of patients about to undergo coronary artery surgery. , 1992, British journal of anaesthesia.

[81]  A. Akane,et al.  Increased urinary morphine, codeine and tetrahydropapaveroline in parkinsonian patient undergoing L-3,4-dihydroxyphenylalanine therapy: a possible biosynthetic pathway of morphine from L-3,4-dihydroxyphenylalanine in humans. , 1992, The Journal of pharmacology and experimental therapeutics.

[82]  T. Hedner,et al.  Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat , 1992, Pain.

[83]  A. Rane,et al.  A conspicuous down-regulating effect of morphine on essential steroid hydroxylation reactions and certain drug N-demethylations , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[84]  M. Slevin,et al.  Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide. , 1992, British Journal of Cancer.

[85]  G. Pollack,et al.  Enterohepatic recirculation and renal metabolism of morphine in the rat. , 1991, Journal of pharmaceutical sciences.

[86]  A. Somogyi,et al.  Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[87]  A. Herz,et al.  Analgesic effect of intraarticular morphine after arthroscopic knee surgery. , 1991, The New England journal of medicine.

[88]  J. Chaumeil,et al.  Systemic morphine pharmacokinetics after ocular administration. , 1991, Journal of pharmaceutical sciences.

[89]  W. Runciman,et al.  Physiological disposition of i.v. morphine in sheep. , 1991, British journal of anaesthesia.

[90]  S. P. Ashmore,et al.  Simple method for the determination of morphine and its active glucuronide metabolite in human plasma by high-performance liquid chromatography with electrochemical detection. , 1991, Journal of chromatography.

[91]  H. Thaler,et al.  Chronic morphine therapy for cancer pain , 1991, Neurology.

[92]  A. Gulati,et al.  Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels. , 1991, The Journal of pharmacology and experimental therapeutics.

[93]  M. Zenk,et al.  Formation of the morphine precursor salutaridine is catalyzed by a cytochrome P-450 enzyme in mammalian liver , 1991 .

[94]  S. Davis,et al.  Determination of morphine and 6-acetylmorphine in plasma by high-performance liquid chromatography with fluorescence detection. , 1991, Journal of chromatography.

[95]  P. Glare,et al.  A Simple, Rapid Method for the Simultaneous Determination of Morphine and Its Principal Metabolites in Plasma Using High‐Performance Liquid Chromatography and Fluorometric Detection , 1991, Therapeutic drug monitoring.

[96]  L. Christrup,et al.  Utilization of prodrugs to enhance the transdermal absorption of morphine , 1991 .

[97]  A. Somogyi,et al.  High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies. , 1991, Journal of chromatography.

[98]  J. Ponte,et al.  Morphine-6-glucuronide: effects on ventilation in normal volunteers , 1991, Pain.

[99]  N el Tayar,et al.  Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity. , 1991, Journal of medicinal chemistry.

[100]  W. Hayton,et al.  Chronic ethanol consumption causes increased glucuronidation of morphine in rabbits. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[101]  N. Hanioka,et al.  Species difference of site-selective glucuronidation of morphine. , 1991, Journal of pharmacobio-dynamics.

[102]  J. Lipp.  Possible mechanisms of morphine analgesia. , 1991, Clinical neuropharmacology.

[103]  E. Cone,et al.  Forensic drug testing for opiates. II. Metabolism and excretion rate of morphine in humans after morphine administration. , 1991, Journal of analytical toxicology.

[104]  J. Lee,et al.  Sensitive and specific radioimmunoassays for opiates using commercially available materials. I: Methods for the determinations of morphine and hydromorphone. , 1991, Journal of pharmaceutical sciences.

[105]  L. Reiff,et al.  Morphine-6-glucuronide: receptor binding profile in bovine caudate nucleus. , 1991, Pharmacology & toxicology.

[106]  L. Rossi,et al.  Regulation of the expression of the sex-specific isoforms of cytochrome P-450 in rat liver. , 1991, European journal of biochemistry.

[107]  T. Hedner,et al.  Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. , 1991, European journal of pharmacology.

[108]  H. Akil,et al.  Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. , 1991, Science.

[109]  T. Yaksh,et al.  Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. , 1990, Anesthesiology.

[110]  R. Portenoy,et al.  The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions , 1990, Pain.

[111]  H. Yamada,et al.  Substrate specificity of guinea pig liver flavin-containing monooxygenase for morphine, tropane and strychnos alkaloids. , 1990, Biochemical pharmacology.

[112]  E. Zecca,et al.  Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man , 1990, Pain.

[113]  Y. Kumagai,et al.  A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig. , 1990, The Journal of pharmacology and experimental therapeutics.

[114]  E. Camporesi,et al.  Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. , 1990, The American review of respiratory disease.

[115]  J. Mørland,et al.  Morphine-6-Glucuronide might Mediate the Prolonged Opioid Effect of Morphine in Acute Renal Failure , 1990, Human & experimental toxicology.

[116]  L. Mather,et al.  Improved method for morphine determination in biological fluids and tissues: rapid, sensitive and selective , 1990, The Journal of pharmacy and pharmacology.

[117]  N. Hanioka,et al.  Species differences in metabolism of codeine: urinary excretion of codeine glucuronide, morphine-3-glucuronide and morphine-6-glucuronide in mice, rats, guinea pigs and rabbits. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[118]  A. Rane,et al.  Sex differences and endocrine regulation of morphine oxidation in rat liver. , 1990, Biochemical pharmacology.

[119]  K. Kitamura,et al.  [Morphine hydrochloride suppositories. II. Bioavailability of morphine hydrochloride suppositories in dogs]. , 1990, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[120]  S. Peat,et al.  Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine. , 1990, British journal of anaesthesia.

[121]  M. Konishi,et al.  On-line clean-up system of plasma sample for simultaneous determination of morphine and its metabolites in cancer patients by high-performance liquid chromatography. , 1990, Journal of pharmaceutical sciences.

[122]  Paul Glare,et al.  Normorphine, a neurotoxic metabolite? , 1990, The Lancet.

[123]  A. Rane,et al.  Disposition of morphine-3-glucuronide in the pregnant rhesus monkey. , 1990, Pharmacology & toxicology.

[124]  J. Plummer,et al.  Influence of polarity on dose-response relationships of intrathecal opioids in rats , 1990, Pain.

[125]  C. von Bahr,et al.  Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors. , 1990, Pharmacology & toxicology.

[126]  A. Rane,et al.  The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. , 1990, British journal of clinical pharmacology.

[127]  R. Putnam,et al.  Steady-state pHi, buffering power, and effect of CO2 in a smooth muscle-like cell line. , 1990, The American journal of physiology.

[128]  K. Shen,et al.  Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. , 1990, Trends in pharmacological sciences.

[129]  W. J. Merrell,et al.  The effect of halothane on morphine disposition: relative contributions of the liver and kidney to morphine glucuronidation in the dog. , 1990, Anesthesiology.

[130]  R Melzack,et al.  The tragedy of needless pain. , 1990, Scientific American.

[131]  S. Joel,et al.  Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine‐6‐glucuronide , 1990, Clinical pharmacology and therapeutics.

[132]  M. Yeadon,et al.  Opioids and respiration , 1989, Progress in Neurobiology.

[133]  R. Albrecht,et al.  Ventilatory effects of fourth cerebroventricular infusions of morphine-6- or morphine-3-glucuronide in the awake dog. , 1989, Anesthesiology.

[134]  W. Fleming,et al.  Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. , 1989, Pharmacological reviews.

[135]  G. Pasternak,et al.  Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. , 1989, The Journal of pharmacology and experimental therapeutics.

[136]  C. Johanson,et al.  The mammalian choroid plexus. , 1989, Scientific American.

[137]  B. Burchell,et al.  The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme. , 1989, Biochemical pharmacology.

[138]  A. Bodenham,et al.  Extrahepatic morphine metabolism in man during the anhepatic phase of orthotopic liver transplantation. , 1989, British journal of anaesthesia.

[139]  J. Plummer,et al.  Influence of a high‐fat meal on the absorption of morphine from oral solutions , 1989, Clinical pharmacology and therapeutics.

[140]  R. Harbison,et al.  Perturbation of glutathione by a central action of morphine. , 1989, Toxicology.

[141]  R. D. Peterson,et al.  Comparative ventilatory effects of intravenous versus fourth cerebroventricular infusions of morphine sulfate in the unanesthetized dog. , 1989, Anesthesiology.

[142]  H. McQuay,et al.  Opioids in chronic pain. , 1989, British journal of anaesthesia.

[143]  D N Bateman,et al.  Age and the pharmacokinetics of morphine. , 1989, Age and ageing.

[144]  K. Oguri,et al.  Synthesis and analgesic effect of normorphine-3- and -6-glucuronides. , 1989, Chemical & pharmaceutical bulletin.

[145]  V. Hruby,et al.  Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. , 1989, The Journal of pharmacology and experimental therapeutics.

[146]  J. Hasselström,et al.  Long lasting respiratory depression induced by morphine-6-glucuronide? , 1989, British journal of clinical pharmacology.

[147]  A. Dickenson,et al.  The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide and normorphine in the rat , 1989, Brain Research.

[148]  F. Tagliaro,et al.  High-performance liquid chromatographic determination of morphine in biological samples: an overview of separation methods and detection techniques. , 1989, Journal of chromatography.

[149]  M. Kuramoto,et al.  Characteristics of the gastrointestinal absorption of morphine in rats. , 1989, Chemical & pharmaceutical bulletin.

[150]  M Danhof,et al.  Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. , 1988, The Journal of pharmacology and experimental therapeutics.

[151]  F. Tagliaro,et al.  HPLC determination of morphine with amperometric detection at low potentials under basic pH conditions , 1988 .

[152]  B. Winblad,et al.  Human brain metabolism of morphine and naloxone , 1988, Pain.

[153]  J. Svensson,et al.  Glucuronidation of morphine in human kidney microsomes. , 1988, Pharmacology & toxicology.

[154]  S. Boyea,et al.  Accumulation and clearance of morphine-3-beta-D-glucuronide in fetal lambs. , 1988, The Journal of pharmacology and experimental therapeutics.

[155]  G. Aherne,et al.  Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients. , 1988, British journal of anaesthesia.

[156]  M. Paule,et al.  Centrally mediated opioid induced depression of hepatic glutathione: effects of intracerebroventricular administration of mu, kappa, sigma and delta agonists. , 1988, Toxicology.

[157]  J. Miners,et al.  In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation. , 1988, Biochemical pharmacology.

[158]  Y. Ohno,et al.  Comparative evaluation of different pathways for the liver toxicity of morphine using freshly isolated hepatocytes. , 1988, Biochemical pharmacology.

[159]  L. Hammar,et al.  Human liver morphine UDP‐glucuronyl transferase enantioselectivity and inhibition by opioid congeners and oxazepam , 1988, British journal of pharmacology.

[160]  W. Kromer.  Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. , 1988, Pharmacological reviews.

[161]  S. Joel,et al.  ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDE , 1988, The Lancet.

[162]  T. Yaksh,et al.  Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. , 1988, The Journal of pharmacology and experimental therapeutics.

[163]  G. Pasternak,et al.  Morphine-6-glucuronide, a potent mu agonist. , 1987, Life sciences.

[164]  C. Weitz,et al.  Synthesis of the skeleton of the morphine molecule by mammalian liver , 1987, Nature.

[165]  A. Madge.  History of pharmacy. , 1987, Journal of the Royal Society of Health.

[166]  P. Portoghese,et al.  Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice. , 1987, The Journal of pharmacology and experimental therapeutics.

[167]  K. Oguri,et al.  Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position. , 1987, Life sciences.

[168]  J. Houston,et al.  Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[169]  F. Balis,et al.  Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatrie cancer patients and rhesus monkeys , 1987, Pain.

[170]  G. Cardinale,et al.  Chemical characterization and regulation of endogenous morphine and codeine in the rat. , 1987, The Journal of pharmacology and experimental therapeutics.

[171]  J. Mazoit,et al.  Pharmacokinetics of Unchanged Morphine in Normal and Cirrhotic Subjects , 1987, Anesthesia and analgesia.

[172]  G. Cardinale,et al.  Morphine and codeine are endogenous components of human cerebrospinal fluid , 1987 .

[173]  S. Orrenius,et al.  On the mechanisms of glutathione depletion in hepatocytes exposed to morphine and ethylmorphine. , 1986, Toxicology.

[174]  H. Derendorf,et al.  Coulometric high-performance liquid chromatographic analysis of morphine in biological fluids. , 1986, Journal of pharmaceutical sciences.

[175]  M. Millan.  Multiple opioid systems and pain , 1986, Pain.

[176]  G. Park,et al.  Pharmacokinetics of morphine in two children before and after liver transplantation. , 1986, British journal of anaesthesia.

[177]  R. Branch,et al.  Extrahepatic glucuronidation of morphine in the dog. , 1986, Drug metabolism and disposition: the biological fate of chemicals.

[178]  S. Braver,et al.  The measurement of clinical pain intensity: a comparison of six methods , 1986, Pain.

[179]  G. Yost,et al.  Substrate-selective induction of rabbit hepatic UDP-glucuronyltransferases by ethanol and other xenobiotics. , 1986, Biochemical pharmacology.

[180]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[181]  K. Lynn,et al.  Renal failure does not impair the metabolism of morphine. , 1986, British journal of clinical pharmacology.

[182]  A. Casy,et al.  Opioid Analgesics , 1986, Springer US.

[183]  A. Brossi,et al.  Presence and formation of codeine and morphine in the rat. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[184]  Y. Ohno,et al.  Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity. , 1986, Biochemical pharmacology.

[185]  G. Pasternak,et al.  Minireview: Multiple MU opiate receptors , 1986 .

[186]  T. Yaksh,et al.  High Doses of Spinal Morphine Produce a Nonopiate Receptormediated Hyperesthesia: Clinical and Theoretic Implications , 1986, Anesthesiology.

[187]  Russell K. Portenoy,et al.  Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases , 1986, Pain.

[188]  J. Mørland,et al.  Ethanol inhibition of codeine and morphine metabolism in isolated rat hepatocytes. , 1986, The Journal of pharmacology and experimental therapeutics.

[189]  G. Pasternak,et al.  Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. , 1986, The Journal of pharmacology and experimental therapeutics.

[190]  T. Tephly,et al.  Isolation and purification of rat liver morphine UDP-glucuronosyltransferase. , 1986, Molecular pharmacology.

[191]  J. Lamberty,et al.  A Double‐blind Comparison of the Efficacy of Methadone and Morphine in Postoperative Pain Control , 1986, Anesthesiology.

[192]  P. Duke,et al.  Kinetic disposition of morphine in young males after intravenous loading and maintenance infusions , 1986, Canadian Anaesthetists' Society journal.

[193]  A. Rane,et al.  Presystemic glucuronidation of morphine in humans and rhesus monkeys: subcellular distribution of the UDP-glucuronyltransferase in the liver and intestine. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[194]  A. Dickenson,et al.  Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn , 1986, Pain.

[195]  G. Pasternak,et al.  Visualization of mu1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[196]  J. Svensson,et al.  Natural (-)- and unnatural (+)-enantiomers of morphine: comparative metabolism and effect of morphine and phenobarbital treatment. , 1985, The Journal of pharmacology and experimental therapeutics.

[197]  J. Fujimoto,et al.  Analgesic potencies of morphine 3- and 6-sulfates after intracerebroventricular administration in mice: relationship to structural characteristics defined by mass spectrometry and nuclear magnetic resonance. , 1985, Journal of pharmaceutical sciences.

[198]  G. Aherne,et al.  MORPHINE-6-GLUCURONIDE, AN IMPORTANT FACTOR IN INTERPRETING MORPHINE RADIOIMMUNOASSAYS , 1985, The Lancet.

[199]  K. Foley.  The treatment of cancer pain. , 1985, The New England journal of medicine.

[200]  G. Murphy,et al.  A rapid method for the determination of blood morphine concentration suitable for use in studies involving acute and chronic pain. , 1985, Journal of pharmacological methods.

[201]  S. Yamano,et al.  Purification and characterization of guinea pig liver morphine 6-dehydrogenase. , 1985, The Journal of biological chemistry.

[202]  J. Sear,et al.  RENAL FAILURE AND THE USE OF MORPHINE IN INTENSIVE CARE , 1985, The Lancet.

[203]  L. Kager,et al.  Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. , 1985, British journal of clinical pharmacology.

[204]  J. Noordhoek,et al.  Glucuronidation of morphine and six beta 2-sympathomimetics in isolated rat intestinal epithelial cells. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[205]  M. Correia,et al.  Morphine metabolism revisited. II. Isolation and chemical characterization of a glutathionylmorphine adduct from rat liver microsomal preparations. , 1984, Chemico-biological interactions.

[206]  A. Aitkenhead,et al.  PHARMACOKINETICS OF SINGLE-DOSE I.V.MORPHINE IN NORMAL VOLUNTEERS AND PATIENTS WITH END-STAGE RENAL FAILURE , 1984 .

[207]  J. Hook,et al.  Characteristics of renal UDP-glucuronyltransferase. , 1984, Life sciences.

[208]  R. Moore,et al.  Sensitive and Specific Morphine Radioimmunoassay with Iodine Label: Pharmacokinetics of Morphine in Man after Intravenous Administration , 1984, Annals of clinical biochemistry.

[209]  J. Scherrmann,et al.  Combined liquid-solid chromatography and radioimmunoassay for determination of morphine in human fluids. , 1984, Journal of pharmacological methods.

[210]  A. Rane,et al.  Morphine glucuronidation in the rhesus monkey: a comparative in vivo and in vitro study. , 1984, The Journal of pharmacology and experimental therapeutics.

[211]  M. Correia,et al.  Morphine metabolism revisited: I. Metabolic activation of morphine to a reactive species in rats. , 1984, Chemico-biological interactions.

[212]  C. Regnard,et al.  Metabolism of narcotics. , 1984, British medical journal.

[213]  R. Moore,et al.  HPLC of Morphine with Electrochemical Detection: Analysis in Human Plasma , 1984, Annals of clinical biochemistry.

[214]  G. Rein,et al.  Characterization of Human Brain Phenolsulphotransferase , 1984, Journal of neurochemistry.

[215]  W R Martin,et al.  Pharmacology of opioids. , 1983, Pharmacological reviews.

[216]  J. Newton,et al.  Sex differences in the excretion of glucuronide conjugates: the role of intrarenal glucuronidation. , 1983, The Journal of pharmacology and experimental therapeutics.

[217]  P. Duke,et al.  Age‐related morphine kinetics , 1983, Clinical pharmacology and therapeutics.

[218]  J. Svensson,et al.  Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence. , 1983, British journal of clinical pharmacology.

[219]  T. Terao,et al.  Studies on the mechanism of covalent binding of morphine metabolites to proteins in mouse. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[220]  F. Roch-Ramel,et al.  Transport and metabolism of [3H]morphine in isolated, nonperfused proximal tubular segments of the rabbit kidney. , 1982, The Journal of pharmacology and experimental therapeutics.

[221]  S. Muldoon,et al.  Determination of morphine in cerebrospinal fluid and plasma by high-performance liquid chromatography with electrochemical detection. , 1982, Journal of chromatography.

[222]  T. Terao,et al.  Effect of morphinone on opiate receptor binding and morphine-elicited analgesia. , 1982, Life sciences.

[223]  S. Soldin,et al.  Analysis of morphine in serum by high performance liquid chromatography with amperometric detection. , 1982, Therapeutic drug monitoring.

[224]  J. Fujimoto,et al.  Trans-stilbene oxide administration increased hepatic glucuronidation of morphine but decreased biliary excretion of morphine glucuronide in rats. , 1982, The Journal of pharmacology and experimental therapeutics.

[225]  H. Szeto,et al.  A comparison of morphine and methadone disposition in the maternal-fetal unit. , 1982, American journal of obstetrics and gynecology.

[226]  A. Rane,et al.  Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. , 1982, Journal of chromatography.

[227]  W. J. Brock,et al.  Hepatic morphine and estrone glucuronyltransferase activity and morphine biliary excretion in the isolated perfused rat liver. Effect of pregnancy and estradiol-17 beta treatment. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[228]  C. Bahr,et al.  Glucuronidation of Morphine in Human Liver and Interaction with Oxazepam , 1982, Acta anaesthesiologica Scandinavica. Supplementum.

[229]  A. Rane,et al.  Distribution of UDP‐glucuronyltransferase in different human foetal tissues [letter] , 1982 .

[230]  T. Terao,et al.  Protective effect of sulfhydryl compounds on acute toxicity of morphinone. , 1982, Life sciences.

[231]  J. Tinker,et al.  Cardiocirculatory Effects of Prolonged Administration of Isoflurane in Normocarbic Human Volunteers , 1982, Acta anaesthesiologica Scandinavica.

[232]  L. Maguire,et al.  Prevention of narcotic-induced constipation. , 1981, The New England journal of medicine.

[233]  R. Branch,et al.  Normal metabolism of morphine in cirrhosis. , 1981, Gastroenterology.

[234]  A. Rane,et al.  Inhibition of morphine glucuronidation by oxazepam in human fetal liver microsomes. , 1981, Drug metabolism and disposition: the biological fate of chemicals.

[235]  L. Paalzow,et al.  Morphine kinetics in cancer patients , 1981, Clinical pharmacology and therapeutics.

[236]  C. Hug,et al.  Tissue Redistribution of Fentanyl and Termination of Its Effects in Rats , 1981, Anesthesiology.

[237]  R. Butz,et al.  Relationships between immunogen structure and antisera specificity in the narcotic alkaloid series. , 1981, Clinical chemistry.

[238]  S. Vatner,et al.  Morphine Effects on Cardiac Output and Regional Blood Flow Distribution in Conscious Dogs , 1981, Anesthesiology.

[239]  S. Schenker,et al.  Lack of tolerance and rapid recovery of cimetidine-inhibited chlordiazepoxide (Librium) elimination. , 1981, Gastroenterology.

[240]  D. Jasinski.  OPIATE WITHDRAWAL SYNDROME: ACUTE AND PROTRACTED ASPECTS , 1981, Annals of the New York Academy of Sciences.

[241]  C. Woolf.  Intrathecal high dose morphine produces hyperalgesia in the rat , 1981, Brain Research.

[242]  C. Hug,et al.  Pharmacokinetics of Intravenous Morphine in Patients Anesthetized with Enflurane–Nitrous Oxide , 1981, Anesthesiology.

[243]  P. Edlund.  Determination of opiates in biological samples by glass capillary gas chromatography with electron-capture detection. , 1981, Journal of chromatography.

[244]  C. Hug,et al.  Pharmacokinetics of Morphine Injected Intravenously into the Anesthetized Dog , 1981, Anesthesiology.

[245]  J. Fujimoto,et al.  Site of action of dehydrocholate in inhibiting the biliary excretion of morphine in the isolated in situ perfused rat liver. , 1980, The Journal of pharmacology and experimental therapeutics.

[246]  R. Parker,et al.  Enterohepatic recycling of phenolphthalein, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid in the rat. Hydrolysis of glucuronic acid conjugates in the gut lumen. , 1980, Xenobiotica; the fate of foreign compounds in biological systems.

[247]  S. Harris,et al.  Determination of morphine by liquid chromatography with electrochemical detection. , 1980, Analytical chemistry.

[248]  J. Roth,et al.  Sulfation of Dopamine and Other Biogenic Amines by Human Brain Phenol Sulfotransferase , 1980, Journal of neurochemistry.

[249]  D. Chamberlain,et al.  Haemodynamic effects of intravenous morphine in patients with acute myocardial infarction complicated by severe left ventricular failure. , 1980, British medical journal.

[250]  H. Jick,et al.  Addiction rare in patients treated with narcotics. , 1980, The New England journal of medicine.

[251]  H. Mehendale,et al.  Absence of metabolism of morphine during accumulation by isolated perfused rabbit lung. , 1979, Drug metabolism and disposition: the biological fate of chemicals.

[252]  M. W. White.  Determination of morphine and its major metabolite, morphine-3-glucuronide, in blood by high-performance liquid chromatography with electrochemical detection. , 1979, Journal of chromatography.

[253]  C. Pinsky,et al.  Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity , 1979, Brain Research.

[254]  E. R. Garrett,et al.  Pharmacokinetics of morphine and its surrogates. III: Morphine and morphine 3-monoglucuronide pharmacokinetics in the dog as a function of dose. , 1979, Journal of pharmaceutical sciences.

[255]  I. Ho,et al.  Effects of acute and continuous morphine administration on serum glutamate oxalacetate transaminase and glutamate pyruvate transaminase activities in the mouse. , 1979, Biochemical pharmacology.

[256]  H. Krebs,et al.  Isolation and identification of morphine N‐oxide α and β‐dihydromorphines, β‐ or γ‐isomorphine, and hydroxylated morphine as morphine metabolites in several mammalian species , 1979 .

[257]  K. Mullis,et al.  Morphine persistence in rat brain and serum after single doses. , 1979, The Journal of pharmacology and experimental therapeutics.

[258]  E. R. Garrett,et al.  Pharmacokinetics of morphine and its surrogates I: comparisons of sensitive assays of morphine in biological fluids and application to morphine pharmacokinetics in the dog. , 1978, Journal of pharmaceutical sciences.

[259]  D. Eaton,et al.  Uptake of morphine and nalorphine by isolated rat hepatocytes. , 1978, The Journal of pharmacology and experimental therapeutics.

[260]  M. Kreek,et al.  Hepatic extraction of long- and short-acting narcotics in the isolated perfused rabbit liver. , 1978, Gastroenterology.

[261]  T. Tephly,et al.  The inhibition of morphine: UDP-glucuronyltransferase in rabbit liver microsomes by cyproheptadine. , 1977, Life sciences.

[262]  K. Rice,et al.  Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors? , 1977, Science.

[263]  J. Hempstead,et al.  Pharmacokinetics of Morphine: Effects of Hypercarbia on Serum and Brain Morphine Concentrations in the Dog , 1977, Anesthesiology.

[264]  H. Borison,et al.  Naloxone antagonizes narcotic self blockade of emesis in the cat. , 1977, The Journal of pharmacology and experimental therapeutics.

[265]  H. Krebs,et al.  Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans. , 1977, Journal of pharmaceutical sciences.

[266]  R. Mcquinn,et al.  Biotransformation of morphine to dihydromorphinone and normorphine in the mouse, rat, rabbit, guinea pig, cat, dog, and monkey. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[267]  W. J. Cole,et al.  Application of the extractive alkylation technique to the pentafluorobenzylation of morphine (a heroin metabolite) and surrogates, with special reference to the quantitative determination of plasma morphine levels using mass fragmentography. , 1977, Journal of chromatography.

[268]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[269]  J. Judis.  Binding of codeine, morphine, and methadone to human serum proteins. , 1977, Journal of pharmaceutical sciences.

[270]  T. Tephly,et al.  Morphine metabolism. V. Isolation of separate glucuronyltransferase activities for morphine and p-nitrophenol from rabbit liver microsomes. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[271]  K. Oguri,et al.  Effect of morphine and its conjugates on the isolated ileal preparation of guinea-pig. , 1977, Chemical & pharmaceutical bulletin.

[272]  W. Martin,et al.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[273]  A. Lajtha,et al.  Factors affecting morphine uptake into kidney slices. , 1976, Biochemical pharmacology.

[274]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[275]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[276]  K. Bock,et al.  Glucuronidation of paracetamol, morphine and 1-naphthol in the rat intestinal loop. , 1976, Biochemical pharmacology.

[277]  W. Sherman,et al.  Mass fragmentography of morphine: relationship between brain levels and analgesic activity. , 1976, The Journal of pharmacology and experimental therapeutics.

[278]  C. T. Walsh,et al.  Studies of the enterohepatic circulation of morphine in the rat. , 1975, The Journal of pharmacology and experimental therapeutics.

[279]  R. Twycross.  Diseases of the central nervous system. Relief of terminal pain. , 1975, British medical journal.

[280]  W. S. Koski,et al.  Microelectrometric titration measurement of the pKa's and partition and drug distribution coefficients of narcotics and narcotic antagonists and their pH and temperature dependence. , 1975, Journal of medicinal chemistry.

[281]  H. Don,et al.  Narcotic analgesics in anuric patients. , 1975, Anesthesiology.

[282]  W. Bennett,et al.  Morphine and phenytoin binding to plasma proteins in renal and hepatic failure , 1975, Clinical pharmacology and therapeutics.

[283]  L. Paalzow,et al.  Quantitative determination of morphine in biological samples by gas‐liquid chromatography and electron‐capture detection , 1975, The Journal of pharmacy and pharmacology.

[284]  G. Olsen.  Morphine binding to human plasma proteins , 1975, Clinical pharmacology and therapeutics.

[285]  S. Spector,et al.  The influence of physiologic and pharmacologic factors on the disposition of morphine as determined by radioimmunoassay. , 1974, The Journal of pharmacology and experimental therapeutics.

[286]  W H Oldendorf,et al.  Lipid Solubility and Drug Penetration of the Blood Brain Barrier , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[287]  E. Eger,et al.  The cardiovascular and respiratory effects of isoflurane-nitrous oxide anaesthesia , 1974, Canadian Anaesthetists' Society journal.

[288]  T. Tephly,et al.  Morphine metabolism. II. Studies on morphine glucuronyltransferase activity in intestinal microsomes of rats. , 1974, Drug metabolism and disposition: the biological fate of chemicals.

[289]  S. Brunk,et al.  Morphine metabolism in man , 1974 .

[290]  R. Peterson,et al.  Effect of chloroquine and phenobarbital on morphine glucuronidation and biliary excretion in the rat. , 1974, Biochemical pharmacology.

[291]  S. Brunk,et al.  Morphine metabolism in man: Effect of aspirin , 1974, Clinical pharmacology and therapeutics.

[292]  E. J. Simon,et al.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[293]  K. Oguri,et al.  Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats. , 1973, Biochemical pharmacology.

[294]  Davis Le,et al.  Species differences in plasma protein binding of morphine and codeine. , 1973, American journal of veterinary research.

[295]  S. Snyder,et al.  Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.

[296]  R. Schulz,et al.  Inactivity of narcotic glucuronides as analgesics and on guinea-pig ileum. , 1972, The Journal of pharmacology and experimental therapeutics.

[297]  K. Oguri,et al.  Chemical synthesis and analgesic effect of morphine ethereal sulfates. , 1972, Life sciences. Pt. 1: Physiology and pharmacology.

[298]  E. Vesell,et al.  Disposition of Morphine in Man , 1971, Science.

[299]  J. Fujimoto,et al.  Inhibition of renal tubular transport of morphine by -diethylaminoethyl diphenylpropylacetate in the chicken. , 1971, Biochemical pharmacology.

[300]  K. Oguri,et al.  Analgesic effect of morphine glucuronides. , 1971, The Tohoku journal of experimental medicine.

[301]  S. Spector.  Quantitative determination of morphine in serum by radioimmunoassay. , 1971, The Journal of pharmacology and experimental therapeutics.

[302]  T. Muraki.  Uptake of morphine-3-glucuronide by choroid plexuses in vitro. , 1971, European journal of pharmacology.

[303]  L. A. Woods,et al.  Metabolism of morphine by cats. , 1971, Journal of pharmaceutical sciences.

[304]  K. Oguri,et al.  Metabolism of drugs. LXIX. Studies on the urinary metabolites of morphine in several mammlian species. , 1970, Chemical & pharmaceutical bulletin.

[305]  L. A. Woods,et al.  Morphine conjugates in the dog. , 1970, Biochemical pharmacology.

[306]  L. A. Woods,et al.  Determination of radioactive-labeled codeine, morphine, dihydromorphine, and their metabolites in biological materials. , 1970, Journal of pharmaceutical sciences.

[307]  M. H. Aprison.  Advances in biochemical psychopharmacology: Volume 1, edited by E. Costa and P. Greengard, Raven press (1969) , 1970 .

[308]  G. Wilkinson,et al.  Sub-microgram estimation of morphine in biological fluids by gas-liquid chromatography. , 1969, Biochemical pharmacology.

[309]  H. Loh,et al.  Simultaneous quantitative assessment of morphine tolerance and physical dependence. , 1969, The Journal of pharmacology and experimental therapeutics.

[310]  L. A. Woods,et al.  Physiologic disposition of N-C14-methyl-codeine in the rat. , 1969, The Journal of pharmacology and experimental therapeutics.

[311]  A. Takemori.  An ultrasensitive method for the determination of morphine and its application in experiments in vitro and in vivo. , 1968, Biochemical pharmacology.

[312]  J. Fujimoto,et al.  The tubular transport and metabolism of morphine-N-methyl-C14 by the chicken kidney. , 1967, The Journal of pharmacology and experimental therapeutics.

[313]  C. Hansch,et al.  The effect of intramolecular bydrophobic bonding on partition coefficients , 1967 .

[314]  C. Hug.  Transport of narcotic analgesics by choroid plexus and kidney tissue in vitro. , 1967, Biochemical pharmacology.

[315]  G. W. Kirby.  Biosynthesis of the Morphine Alkaloids , 1967, Science.

[316]  A. Takemori,et al.  Studies on the uptake of morphine by the choroid plexus in vitro. , 1966, The Journal of pharmacology and experimental therapeutics.

[317]  H. Kupferberg,et al.  A SENSITIVE FLUOROMETRIC ASSAY FOR MORPHINE IN PLASMA AND BRAIN. , 1964, The Journal of pharmacology and experimental therapeutics.

[318]  H. Rapoport,et al.  SOME ASPECTS OF THE FATE AND RELATIONSHIP OF THE N-METHYL GROUP OF MORPHINE TO ITS PHARMACOLOGICAL ACTIVITY. , 1963, Journal of medicinal chemistry.

[319]  J. Laidlaw,et al.  Morphine tolerance in hepatic cirrhosis. , 1961, Gastroenterology.

[320]  L. Lasagna,et al.  Analgesic potency of normorphine in patients with postoperative pain. , 1958, The Journal of pharmacology and experimental therapeutics.

[321]  A. Takemori,et al.  Metabolic N- and O-demethylation of morphine- and morphinan-type analgesics. , 1958, The Journal of pharmacology and experimental therapeutics.

[322]  J. Axelrod.  Possible mechanism of tolerance to narcotic drugs. , 1956, Science.

[323]  J. Axelrod.  The enzymatic N-demethylation of narcotic drugs. , 1956, The Journal of pharmacology and experimental therapeutics.

[324]  J. W. Miller,et al.  Rat tissue levels of carbon-14 labeled analgetics as related to pharmacological activity. , 1955, The Journal of pharmacology and experimental therapeutics.

[325]  L. A. Woods.  Distribution and fate of morphine in non-tolerant and tolerant dogs and rats. , 1954, The Journal of pharmacology and experimental therapeutics.

[326]  A H BECKETT,et al.  SYNTHETIC ANALGESICS: STEREOCHEMICAL CONSIDERATIONS , 1954, The Journal of pharmacy and pharmacology.

[327]  H. W. Elliott,et al.  Distribution and Excretion of Radioactivity after Administration of Morphine-N-methyl C14 to Rats.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[328]  L. A. Woods,et al.  Estimation of morphine in biological materials. , 1954, The Journal of pharmacology and experimental therapeutics.

[329]  M. Gates,et al.  The Synthesis of Morphine , 1952 .

[330]  E. G. Gross,et al.  A METHOD FOR STUDYING THE ANALGETIC EFFECT OF DRUGS IN ANIMALS , 1943 .

[331]  C. Schmidt,et al.  (THE ACTION OF MORPHINE ON THE MAMMALIAN CIRCULATION , 1933 .

[332]  R. Hatcher.  THE UNITED STATES PHARMACOPEIA. , 1908 .

[333]  Nancy Micklewright,et al.  A Comparative , 2008 .

[334]  R. House,et al.  Immunomodulatory effects of in vitro exposure to morphine and its metabolites. , 1995, Pharmacology.

[335]  C. Wolf,et al.  Divergent regulation of cytochrome P450 enzymes by morphine and pethidine: a neuroendocrine mechanism? , 1995, Molecular pharmacology.

[336]  B H Shapiro,et al.  Gender differences in drug metabolism regulated by growth hormone. , 1995, The international journal of biochemistry & cell biology.

[337]  C. Smith,et al.  Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism. , 1995, British journal of clinical pharmacology.

[338]  M. Plotkine,et al.  Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysis. , 1994, Life sciences.

[339]  G. Olsen,et al.  Morphine-6-beta-D-glucuronide respiratory pharmacodynamics in the neonatal guinea pig. , 1994, The Journal of pharmacology and experimental therapeutics.

[340]  R. Pöyhiä,et al.  Liposolubility and protein binding of oxycodone in vitro. , 1994, Pharmacology & toxicology.

[341]  D. Carr,et al.  Morphine-3-glucuronide: silent regulator of morphine actions. , 1994, Life sciences.

[342]  S. Benyhe.  Morphine: new aspects in the study of an ancient compound. , 1994, Life sciences.

[343]  G. Siest,et al.  A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. , 1994, Molecular pharmacology.

[344]  S. Archer.  Chemistry of Nonpeptide Opioids , 1993 .

[345]  B. Cox.  Opioid Receptor-G Protein Interactions: Acute and Chronic Effects of Opioids , 1993 .

[346]  T. Klein,et al.  Drugs of Abuse, Immunity, and AIDS , 1993, Advances in Experimental Medicine and Biology.

[347]  G. Pasternak,et al.  Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist. , 1993, Life sciences.

[348]  M. Levene,et al.  Analysis of morphine and its 3- and 6-glucuronides by high performance liquid chromatography with fluorimetric detection following solid phase extraction from neonatal plasma. , 1993, Biomedical chromatography : BMC.

[349]  P. Déchelotte,et al.  Uptake, 3-, and 6-glucuronidation of morphine in isolated cells from stomach, intestine, colon, and liver of the guinea pig. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[350]  P. Conzen,et al.  The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. , 1992, Anesthesiology.

[351]  R. Jorde,et al.  Increments in glucose, glucagon and insulin after morphine in rats, and naloxone blocking of this effect. , 1992, Life sciences.

[352]  M. Hammarlund-Udenaes,et al.  Estimation of unbound concentrations of morphine from microdialysate concentrations by use of nonlinear regression analysis in vivo and in vitro during steady state conditions. , 1992, Life sciences.

[353]  G. Di Chiara,et al.  Neurobiology of opiate abuse. , 1992, Trends in pharmacological sciences.

[354]  M. Caulfield,et al.  Protein binding of indomethacin, methotrexate and morphine in patients with cancer. , 1992, International journal of clinical pharmacology research.

[355]  K. Franklin,et al.  Morphine-6-glucuronide contributes to rewarding effects of opiates. , 1991, Life sciences.

[356]  A. Somogyi,et al.  Mu receptor binding of some commonly used opioids and their metabolites. , 1991, Life sciences.

[357]  J. Slattery,et al.  Age-dependent morphine partitioning between plasma and cerebrospinal fluid in monkeys. , 1991, Developmental pharmacology and therapeutics.

[358]  P. Glare,et al.  Clinical pharmacokinetics of morphine. , 1991, Therapeutic drug monitoring.

[359]  S. Peat,et al.  Disposition of morphine-6-glucuronide and morphine in healthy volunteers. , 1991, British journal of anaesthesia.

[360]  R. Venn,et al.  Fast reliable assay for morphine and its metabolites using high-performance liquid chromatography and native fluorescence detection. , 1990, Journal of chromatography.

[361]  Maree T. Smith,et al.  Morphine-3-glucuronide--a potent antagonist of morphine analgesia. , 1990 .

[362]  J. Schuberth.  Gas chromatographic-mass spectrometric determination of morphine, codeine and 6-monoacetylmorphine in blood extracted by solid phase. , 1989, Journal of chromatography.

[363]  B. Ellis,et al.  Age and tissue distribution of alkaloids in Papaver somniferum , 1989 .

[364]  P. Ravenscroft,et al.  Determination of morphine in plasma by high-performance liquid chromatography with fluorescence detection. , 1989, Journal of chromatography.

[365]  Y. Kumagai,et al.  (8S)-(glutathion-S-yl)dihydromorphinone, a novel metabolite of morphine from guinea pig bile. , 1989, Drug metabolism and disposition: the biological fate of chemicals.

[366]  D. B. Galloway,et al.  Determination of morphine in human plasma by radioimmunoassay utilising a preliminary liquid-solid extraction. , 1988, Journal of pharmaceutical and biomedical analysis.

[367]  M. Slevin,et al.  An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites. , 1988, Journal of chromatography.

[368]  McQuay Hj.  Pharmacological treatment of neuralgic and neuropathic pain. , 1988 .

[369]  R. Murphy,et al.  Rapid, high-sensitivity method for measurement of morphine in guinea-pig serum. , 1988, Journal of chromatography.

[370]  G. Siest,et al.  A new aspect of the protective functions of the blood-brain barrier: activities of four drug-metabolizing enzymes in isolated rat brain microvessels. , 1988, Life sciences.

[371]  R. Palmour,et al.  Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. , 1988, Life sciences.

[372]  L. Jorgensen,et al.  Morphine-6-glucuronide has high affinity for the opioid receptor. , 1987, Pharmacology & toxicology.

[373]  Y. Mallédant,et al.  Perfusion intraveineuse prolongée de morphine. Etude pharmacocinétique , 1987 .

[374]  T. Tena,et al.  Concentrations of free and conjugated morphine in blood in twenty cases of heroin-related deaths. , 1987, Journal of chromatography.

[375]  A. Townshend,et al.  Determination of morphine in body fluids by high-performance liquid chromatography with chemiluminescence detection. , 1987, The Analyst.

[376]  M. Correia,et al.  Morphine metabolism revisited. III. Confirmation of a novel metabolic pathway. , 1986, Chemico-biological interactions.

[377]  J. Svensson.  Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid chromatography and electrochemical detection , 1986 .

[378]  K. Foley,et al.  Opioid analgesics in the management of clinical pain , 1986 .

[379]  G. Mulder.  Sex differences in drug conjugation and their consequences for drug toxicity. Sulfation, glucuronidation and glutathione conjugation. , 1986, Chemico-biological interactions.

[380]  B. Bivins,et al.  Specific 125I radioimmunoassay for morphine. , 1986, Clinical chemistry.

[381]  J. A. Henry,et al.  High-performance liquid chromatographic assay for morphine with electrochemical detection using an unmodified silica column with a non-aqueous ionic eluent. , 1986, Journal of chromatography.

[382]  A. McKnight,et al.  Recent developments in the bioassay of opioids. , 1985, Regulatory peptides. Supplement.

[383]  K. Bock,et al.  Studies of UDP-glucuronyltransferase activities in human liver microsomes. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[384]  K. Foley,et al.  Morphine radioimmunoassay specificity before and after extraction of plasma and cerebrospinal fluid. , 1983, Journal of pharmaceutical sciences.

[385]  M. Kuhar,et al.  Distribution and physiological significance of opioid receptors in the brain. , 1983, British medical bulletin.

[386]  D. Sitar,et al.  Morphine analysis by high-performance liquid chromatography. , 1983, Journal of chromatography.

[387]  N. Miyata,et al.  Codeine-7,8-oxide (4,5 alpha-epoxy-7 beta, 8 beta-epoxy-3-methoxy-17-methyl-morphinan-6 alpha -ol: identification as a metabolite of codeine. , 1980, Chemical & pharmaceutical bulletin.

[388]  D. Catlin.  Pharmacokinetics of morphine by radioimmunoassay: the influence of immunochemical factors. , 1977, The Journal of pharmacology and experimental therapeutics.

[389]  C. Klaassen,et al.  First-pass effect of morphine in rats. , 1977, The Journal of pharmacology and experimental therapeutics.

[390]  W. Martin.  Drug Addiction I , 1977, Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology.

[391]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[392]  S. Yeh.  Urinary excretion of morphine and its metabolites in morphine-dependent subjects. , 1975, The Journal of pharmacology and experimental therapeutics.

[393]  U Boerner,et al.  The metabolism of morphine and heroin in man. , 1975, Drug metabolism reviews.

[394]  S. Mulé,et al.  Pharmacokinetics and metabolism of (3H) thebaine. , 1974, Xenobiotica; the fate of foreign compounds in biological systems.

[395]  A. Klutch.  A chromatographic investigation of morphine metabolism in rats. Confirmation of N-demethylation of morphine and isolation of a new metabolite. , 1974, Drug metabolism and disposition: the biological fate of chemicals.

[396]  J. Fujimoto,et al.  The isolation of morphine ethereal sulfate from urine of the chicken and cat. , 1969, The Journal of pharmacology and experimental therapeutics.

[397]  L. A. Woods,et al.  The distribution and fate of morphine in the non-tolerant and tolerant monkey. , 1956, The Journal of pharmacology and experimental therapeutics.

[398]  H. Beecher.  Pain in Men Wounded in Battle. , 1946, Annals of surgery.

[399]  H. L. Andrews,et al.  STUDIES ON MODIFICATION OF THE MORPHINE ABSTINENCE SYNDROME BY DRUGS , 1943 .

[400]  C. Lawall,et al.  Four thousand years of pharmacy , 1927 .

[401]  R. Robinson,et al.  CXII.—The morphine group. Part I. A discussion of the constitutional problem , 1923 .